Stay updated with breaking news from Paola casarosa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ludwig Burger FRANKFURT (Reuters) - Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment was shown to reduce body weig. ....
Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment was shown to reduce body weight by close to 19% in a mid-stage trial when looking at participants who had reached the intended dosage level. The detailed results from a mid-stage trial, presented at a meeting of the American Diabetes Association (ADA) in San Diego on Friday, showed a higher efficacy than the 14.9% weight reduction reported by the companies last month in a brief preview of the data. The treatment regimen starts at a low dosage which is stepped up to reach a maintenance level - the same as with weekly weight-loss shot Wegovy by Novo Nordisk and Eli Lilly's Mounjaro, which is expected to win approval for obesity. ....
Proxy advisory firm says Illumina’s CEO, chairman shouldn’t be reelected to the board; Boehringer Ingelheim’s experimental obesity drug is comparable to rivals. ....
Its side effects were "consistent" with what was seen in other injectable GLP-1-based drugs, she said. An experimental drug by Altimmune with the same dual action as Zealand's helped reduce weight by over 10% in a mid-stage trial, data in March showed, but safety concerns sent its shares tumbling. ....
L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu. ....